Llusern Scientific is delighted to be included as one of the point-of-care technologies being considered by the National Institute for Health and Care Excellence (NICE) for urinary tract infections to improve antimicrobial prescribing.
NICE’s guidelines are in development and can be viewed here: https://www.nice.org.uk/guidance/hte7
Llusern Scientific CEO and co-founder, Dr Emma Hayhurst, has been awarded the Innovation Prize from ‘Women in Innovation’. With nearly…
A new abstract published in JAC-Antimicrobial Resistance demonstrates that the Lodestar DX UTI testing system can ‘accurately identify the common…
“NHS Greater Glasgow and Clyde is seeing the launch of a new community diagnostic vehicle, in a move designed to…
Following the success of our first Lodestar DX webinar we are pleased to share that we will be hosting another…
